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1. Introduction 
Heparin is a polysaccharide with unique biological 
effects. It impedes the coagulation of blood by accele- 
rating the reaction between antithrombin (a protease 
inhibitor in plasma) and a number of the proteolytic 
enzymes operating in hemostasis [ 1,2] . Furthermore, 
heparin has the ability to release lipases from tissue 
sites into the circulating blood (for review see ref. [3]). 
The antithrombin-stimulating effect of heparin pre- 
sumably depends on specific binding between the 
polysaccharide and the protein, resulting in a confor- 
mational change in the inhibitor molecule [4,5 ] . The 
mechanism of lipase release is unclear but probably 
involves the formation of heparin-lipase complexes 
[31- 
The relationship between the structure of heparin 
(for review see ref. [6] ) and its biological properties 
has remained elusive. Recent studies have shown that 
heparin preparations may be separated with regard to 
affinity for antithrombin into two distinct fractions, 
one (in the following denoted HAheparin) having high 
affinity for antithrombin and exceedingly higher anti- 
coagulant activity while the other (LA-heparin) has 
low affinity for antithrombin and little or no anti- 
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coagulant activity [7,8] . No apparent structural dis- 
similarity between the two heparin species was noted. 
An oligosaccharide fraction thought to represent the 
antithrombin-binding site of heparin was isolated 
after digestion of the HA-heparin-antithrombin com- 
plex with bacterial heparinase [9]. The gross compo- 
sition of this fragment was similar to that of HA- or 
LA-heparin; it was therefore concluded the binding of 
heparin to antithrombin may require a specific 
sequence of variously substituted sugar residues. 
In the present study HA- and LA-heparins were 
compared on the basis of their ability to interact with 
lipases. Three types of experiments were conducted: 
(a) Affinity chromatography of heparin on immo- 
bilized lipoprotein lipase. 
(b) Heparininduced release of lipoprotein lipase from 
immobilized heparin. 
(c) Heparin-induced release of lipases into the circu- 
lating blood. 
For technical reasons experiments (a) and (b) were 
performed with bovine enzyme whereas the in vivo 
experiment (c)was conduct&d with rats. 
In’all three systems the effects of HA- and LA- 
heparin were virtually indistinguishable, demonstrat- 
ing that the specific structure which binds to anti- 
thrombin differs from that required for interaction 
with lipoprotein lipase (or hepatic lipase). In addition, 
these results demonstrate the occurrence of a native 
mammalian polysaccharide (LA-heparin) having 
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potent lipase-releasing activity but negligeable effect 
on blood coagulation. 
2. Materials and methods 
Heparin (Stage 14, isolated from pig intestinal 
mucosa) obtained from Inolex Pharmaceutical Div., 
Park Forest South, Ill. USA) was purified by repeated 
precipitation with cetylpyridinium chloride [lo] 
from 1.2 M NaCl. Radioactive heparin (specific 
activity 22.5 X lo3 cpm/pg uranic acid) was isolated 
from mouse mastocytoma tissue after labelling in vitro 
with [3H] galactose [9] . Unlabeled or radioactive 
heparin was fractionated by affinity chromatography 
on antithrombin-Sepharose as described [9] . The 
separation of unlabeled heparin is illustrated in fig.1 ;
the t3H]heparin showed an essentially similar elution 
pattern. The anticoagulant activities of unlabeled LA- 
and HA-fractions were 19 BP units/mg and 285 BP 
units/mg, respectively. 
Lipoprotein lipase was purified from bovine skim 
milk essentially as described [l 1] ; however, the 
treatment with rennin was exchanged for batch 
adsorption of the enzyme to heparin-Sepharose. The 
properties of the purified enzyme, were similar to 
those previously described [ 111. 
The heparin-Sepharose used in the enzyme dis- 
placement experiments was prepared as described by 
Iverius [ 121, with the exception that only 40 &g 
heparin was added/ml cyanogen bromide-activated 
Sepharose gel. 
Immobilized lipoprotein lipase was prepared by 
reacting the purified milk enzyme with activated 
Sepharose in the presence of acetylated heparin 
according to a method previously devised for the 
bind~g of ~ti~rombin [8]. The final product con- 
tained about 0.9 mg protein/ml gel (SO-60% recovery 
of the initial enzyme), as estimated by amino acid 
analysis. 
Methods for the determination of uranic acid and 
radioacti~ty have been described [ 131. 
Lipase activities were measured with 3H-labeled 
triolein emulsified in gum arabic as lipid substrate 
[ 141. Lipases from rat plasma were est~ated as 
described in table 1. 
I -LA--+ I 
FRACTION Nr. 
Fig.1. Fractionation of heparin by affinity chromatography on antithrombin-Sepharose 181. Heparin (50 mg) was dissolved in 
25 ml 0.05 M NaCl, 0.05 M Tris-HCl, pH 7.4 and applied to a 75 ml column of antithrombin-Sepharose, equilibrated with the 
same buffer. Gradient elution with sodium chloride (in 0.0s M Tris-HCl, pH 7.4) was started at the point indicated by the arrow. 
Effluent fractions of about 3 ml were collected, analyzed for uranic acid by the carbazole reaction (k,,,) and pooled as indicated 
into low-affinity (LA) and high-affinity (HA) heparin, respectively. The fractions were desalted by dialysis and stored at -2O’C. 
(- - -) NaCl concentration. 
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Table 1 
Lipase activities in rat plasma after i.v. injections of HA- and LA-heparin 
Heparin injected Salt-resistant lipasea (sH cpm X 10T4) Serum-stimulated lipasea (aH cpm X 10e4) 
HA; 0.5 mgd 
LA; 0.5 mg 
HA;10 mg 
LA; 10 mg 
Plasma Washb 0.7 M 1.5 M RecoveryC Plasma Washb 0.7 M 1.5 M RecoveryC 
eluate eluate (%) eluate eluate (%) 
264 56 161 11 86 250 5 11 121 54 
213 47 123 15 86 271 24 6 126 57 
573 270 222 13 88 536 190 65 237 92 
490 277 196 9 99 553 188 17 199 72 
aSalt-resistant lipase (considered to represent hepatic lipase) was determined in the presence of 1 M NaCl [ 141. An approximate 
estimation of serum-stimulated lipase (considered to represent lipoprotein lipase) was obtained by subtracting the activity 
recorded at 1 M NaCl in the absence of serum from that recorded at 0.05 M NaCl in the presence of 5% human serum. These 
concentrations of salt and serum were selected on the basis of preliminary experiments; the concentrations previously found to 
be optimal for human or bovine lipoprotein lipase [ 141 were inhibitory to the rat enzyme. The enzyme activities are expressed 
as cpm [ ‘H]oleic acid liberated in 20 min at 37’C; aB values are adjusted to represent 5 ml of plasma 
bLipases not retained by heparin-Sepharose should probably be at least partly ascribed to the presence of competitory heparin 
(the injected polysaccharide) in the liquid phase. However, see also Fielding, Shore and Fielding [ 161 
CPercent of initial enzyme activity in plasma sample 
dAmount of heparin injected/kg body weight 
Male Sprague-Dawley rats (250 g) were anaesthetized with ether and the heparin preparations (dissolved in 0.9% NaCl) were 
injected i.v. After 7 min blood was collected from the exposed abdominal aorta. A small amount of sodium citrate solution was 
added to prevent blood coagulation and plasma was obtained after centrifugation. 
To about 5 ml plasma were added 1.5 mmol sodium chloride and 1 ml sedimented heparin-Sepharose gel (l-2 mg heparin/ml gel) 
at 4°C. After 90 min the mixture was poured into a small column (i.d. 10 mm). After collection of the effluent the column was 
washed with 20 ml 0.3 M NaCl in 5 mM sodium veronal buffer, pH 7.4, followed by 10 ml 0.5 M NaCl in the same buffer; the 
values in columns ‘Wash’ represent enzyme activity in the combined initial effluent and wash fractions. It was then eluted fist with 
22 ml 0.7 M NaCl and then with 22 ml 1.5 M NaCl in the veronal buffer. Ah buffers contained 1% bovine serum albumin. 
3. Results 
3.1. Affiniv chromatography of heparin on immobi- 
lized lipoprotein lipase 
The chromatography of [‘H]heparin on lipoprotein 
lipase-Sepharose is shown in fig.2A. The polysaccha- 
ride was essentially quantitatively retained by the gel 
and was eluted over a wide range of salt concentrations, 
with a recovery of more than 90% of the radioactivity 
applied to the column. Rechromatography of frac- 
tions eluted at low and at high salt concentration, 
respectively, yielded clearly separated elution patterns 
(fig.2B), suggesting that heparin molecules may differ 
with regard to affinity for lipoprotein lipase. 
Chromatography of LA- and HA-heparin on immo- 
bilized lipoprotein lipase gave virtually identical elution 
profiles (fig.2C). This result thus stands in marked 
contrast to the separation obtained on antithrombin- 
Sepharose, where LA-heparin is eluted as a distinct 
peak at a lower salt concentration than is HA-heparin 
(fig.1). 
3.2. Displacement of lipoprotein lipase from immobi- 
lized heparin 
Lipoprotein lipase was incubated with suspensions 
of heparin-Sepharose, resulting in essentially complete 
binding of the enzyme to the immobilized polysac- 
charide. On addition of heparin to the suspensions 
lipoprotein lipase was displaced from the gel into the 
liquid phase (tig.3). Judging from the dose-response 
curves shown in fig.3, HA-, LA- and unfractionated 
heparin had about equal enzyme-displacing ability. 
3.3. Release of lipases by heparin in vivo 
The interaction of lipoprotein lipase with HA- and 
LA-heparins in vivo was studied by measuring lipase 
activities in blood plasma after intravenous (i.v.) 
injection of the polysaccharides into rats (see table 1 
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Fig.2. Affinity chromatography of [“HJheparin on immo- 
bilized lipoprotein lipase. [3H]Heparin (26 X lo3 cpm or 
less) was dissolved in 0.2 ml 5 mM sodium Verona1 buffer, 
pH 7.4, containing 0.2 M NaCl, and was then applied to a 
small (0.8 ml) column of lipoprotein lipase-Sepharose, 
equilibrated with the same buffer at 4°C. After an equilibra- 
tion period of 15 min the column was first washed with 
4 X 2 ml of NaCl-veronal buffer and was then eluted in a 
stepwise manner with sodium chloride at increasing con- 
centrations in 5 mM veronal buffer. At each Salt concentra- 
tion the effluent was collected in two successive 3 ml 
fractions; the radioactivity of the first fraction always 
exceeded that of the second one. The values 
recorded in the figures represent he sum of the two frac- 
tions. All runs were performed with the same column. 
(A) Unfractionated heparin. Two-thirds of the eluates at 
0.7-0.9 M and at 1.1-1.3 M NaCl, respectively, were 
pooled, diluted with 5 mM Verona1 buffer and reapplied to 
the column (B), yielding the patterns represented by open 
and closed bars, respectively. (C) LA-Heparin (open bars) 
and HA-heparin (closed bars). 
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Fig.3. Release of lipoprotein lipase from heparin-Sepharose 
by addition of heparins to the liquid phase. Lipoprotein 
lipase (about 12 ccg) was added to suspensions of heparin- 
Sepharose (100 ~1 sedimented gel) in 5 mM sodium Verona1 
buffer, pH 7.4, containing 0.32 M NaCl and 1% bovine 
serum albumin. The mixtures (total vol. 1 ml) were placed 
in an oscillating shaker at 4°C in order to keep the gels 
suspended. After about 2 h the tubes were centrifuged 
(2000 X g for 2 min) and samples of the supernatants were 
assayed for lipoprotein lipase. Heparin solution (1 mg/ml) 
was added to the gel suspensions to give the desired concen- 
tration. The tubes were then shaken for another 20 min and 
centrifuged; samples of the supernatants were assayed for 
enzyme activity. The procedure was repeated with further 
additions of heparin. During the entire experiment a total 
volume of 35 d was withdrawn for lipase assay while 100 4 
of heparin solution was added. A control was carried out 
by incubating enzyme in the absence of gel or heparin. 
Unfractionated heparin (o- o), HA-heparin (A -----a), 
LA-heparin (A----- A), and control (o- q ). 
for details). On the basis of preliminary experiments 
with unfractionated heparin two dose levels were 
selected, corresponding to near maximal (10 mg 
heparin/kg body wt) and half-maximal (0.5 mg/kg), 
respectively, release of lipases. Injection of either 
HA- or LA-heparin resulted in the appearance of salt- 
resistant as well as serum-stimulated lipase in the 
blood (table 1). The identities of the two lipases (con- 
sidered to represent hepatic lipase and lipoprotein 
lipase, respectively) were ascertained by chromato- 
graphy on heparin-Sepharose. 
The salt-resistant lipase was largely recovered in a 
0.7 M NaCl eluate whereas the serum-stimulated lipase 
appeared in a 1.5 M fraction (table l), in agreement 
with previous separations of these enzymes [14,15] . 
With both heparins more lipase activity was released 
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by the higher dose. HA- and LA-heparin did not differ 
significantly with regard to type or amount of lipase 
released. 
4. Discussion 
In all systems tested HA- and LA-heparin showed 
equal ability to interact with lipoprotein lipase. Since 
the two types of heparin are differentiated solely on 
the basis of affinity for antithrombin these results 
demonstrate that the specific structure required for 
interaction with antithrombin differs from that 
required for interaction with lipoprotein lipase. This 
conclusion is further supported by the finding that the 
anticoagulant activity of heparin may be selectively 
eliminated by chemical modification of the poly- 
saccharide [ 171. The occurrence in mammalian 
tissues of a native polysaccharide (LA-heparin) that 
affects lipoprotein lipase but lacks effect on blood 
coagulation may have important physiological and 
therapeutic implications. The selective interaction 
between LA-heparin and lipoprotein lipase has 
recently been utilized in purification of the enzyme 
from human plasma [ 181. The detailed structural 
features of the heparin molecule responsible for its 
diverse biological effects remain to be elucidated. 
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